Ann-Hunter Van Kirk

Senior Equity Research Analyst Biopharmaceuticals • Bloomberg Intelligence

Ann-Hunter Van Kirk is a Senior Equity Research Analyst at Bloomberg Intelligence covering the Biopharmaceutical sector with a focus on gene editing, animal health, neuroscience, generics, and eyecare companies. A.H. brings a long career of sell-side healthcare equity research experience from prior positions at Barclays, BMO Capital Markets, and Cantor Fitzgerald. Ms. Van Kirk holds a master’s degree from the London School of Economics and two bachelor’s degrees from Southern Methodist University with honors.

Also speaking

Catriona Crombie

Associate Director of Technology Transfer • LifeArc

Stuart Curbishley

Head of Business and Project Development – Advanced Therapies • University of Birmingham

David Allison

Chief Executive • TREAT-NMD

Event Info


Sponsorship Brochure

Take a look at the 2023 sponsorship opportunities here.

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.